1. Taiwan Stocks

  2. •

    Producer manufacturing

  3. •

    Industrial machinery
Mytrex Health Technologies, Inc.

Mytrex Health Technologies, Inc.

TTPEX:4431
21.10
TWD
-0.10
(-0.47%)
637.55MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
11.97
11.59
12.68
12.58
14.67
14.6
12.87
31.88
7.98
40.28
35.39
48.14
53.23
- -
Basic EPS, GAAP
0.87
1.02
0.95
0.8
0.59
0.32
0.3
10.97
-0.38
-2.52
-1.54
-2.25
-0.45
- -
Free Cash Flow per Basic Share
-0.39
0.09
1.34
1.57
0.74
-0.87
1.62
7.83
-0.47
0.8
-0.8
0.45
5.33
- -
Dividend per Share
0.14
0.24
0.25
0.26
0.27
0.29
0.16
0.13
3.33
- -
- -
- -
- -
- -
Book Value per Share
7.41
8.22
8.89
9.43
9.71
9.85
10
26.62
22.82
26.4
18.47
16.43
16.01
15.92
Tangible Book Value per Share
7.39
8.09
8.56
9.12
9.45
9.65
9.97
26.58
22.79
23.96
16.16
14.13
13.77
13.72
Basic Weighted Avg Shares
33
33
33
33
33
33
31
32
37
37
37
37
37
37
Sales/Revenue/Turnover
394
383
422
418
488
486
398
1,024
292
1,472
1,293
1,759
1,945
- -
Operating Margin (%)
7.76
7.71
9.53
7.31
6.2
3.08
2.69
42.98
-5.31
-3.18
-5.46
-4.37
-0.92
- -
Depreciation Expense
19
16
16
12
14
17
21
27
51
107
97
95
74
- -
Net Income, GAAP
28
34
31
27
20
11
9
352
-14
-92
-56
-82
-17
- -
Effective Tax Rate (%)
19.2
19.33
19.41
23.28
23.96
24.71
- -
20.3
- -
- -
- -
- -
- -
- -
Profit Margin (%)
7.24
8.76
7.46
6.36
4.01
2.19
2.34
34.41
-4.8
-6.25
-4.35
-4.68
-0.85
- -
Working Capital
172
178
202
197
202
186
211
690
525
500
230
286
300
285
LT Debt
10
6
4
2
- -
- -
5
42
44
144
121
113
67
91
Total Equity
242
270
300
317
325
328
333
974
836
968
677
609
585
582
Return on Invested Capital (%)
7.9
7.26
9.44
6.42
5.99
2.95
- -
43.26
- -
- -
- -
- -
- -
- -
Return on Capital (%)
10.41
10.76
9.74
7.97
5.75
3.39
- -
46.39
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
12.34
13.01
11.08
8.73
6.15
3.27
2.82
53.97
-1.55
-10.22
-6.86
-12.92
-2.8
- -

Capital Structure

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
118
98
92
LT Borrowings
- -
- -
- -
LT Finance Leases
103
67
91
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
37
37
37
Market Capitalization
694
632
638

Working Capital

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
716
814
845
Cash, Cash Equivalents & STI
293
422
420
Accounts Receivable, Net
138
130
133
Inventories
220
211
241
Total Current Liabilities
425
514
561
Payables & Accruals
- -
- -
- -
ST Debt
118
98
92
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.07%
-8.5%
-4%
Free Cash Flow
21.09%
67.71%
1,073.47%
Net Income, GAAP
396.04%
75.96%
-79.85%
Sales/Revenue/Turnover
52.19%
73.51%
10.59%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1,759
2025
- -
- -
1,945
2026
- -
- -
- -

Semi-annual Earnings Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-2.25
2025
- -
- -
-0.45
2026
- -
- -
- -

Semi-annual Dividends Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Hung Jen Yang
Full Time Employees
50
Sector
Producer manufacturing
Industry
Industrial machinery
Address
No. 545, Hezun North Road Taoyuan Taiwan 320020
IPO Date
Aug 30, 2011
Website
mytrex.com.tw
Similar Companies
Applied Materials, Inc. (NASDAQ:AMAT)
Oklo Inc. (NYSE:OKLO)
Lam Research Corporation (NASDAQ:LRCX)
Tokyo Electron Ltd. (TSE:8035)
Welspun Corp Limited (NSE:WELCORP)
Symbotic Inc. (NASDAQ:SYM)
Business
Mytrex Health Technologies, Inc. (4431.TWO) develops and manufactures advanced health monitoring devices and wearable technology focused on preventive healthcare and wellness tracking. The company offers core products including the MyTreX Ring, a smart ring for continuous heart rate variability (HRV) monitoring, sleep analysis, and stress detection; the MyTreX Band, a fitness wristband with ECG capabilities, blood oxygen measurement, and activity tracking; and the MyTreX App platform, which integrates AI-driven insights for personalized health reports and telemedicine consultations. Additional services encompass cloud-based data analytics for corporate wellness programs and B2B solutions for medical institutions, targeting consumers, enterprises, and healthcare providers primarily in Asia. Founded in 2018 and headquartered in New Taipei City, Taiwan, Mytrex operates across Taiwan, China, Japan, and expanding into Southeast Asian markets with subsidiaries in Hong Kong. In the past two years, the company secured a strategic partnership with a leading Japanese electronics firm for co-developing next-generation biosensor chips in 2024; completed a NT$500 million funding round led by institutional investors to fuel R&D in AI health algorithms; and launched the MyTreX Pro series in early 2025, featuring FDA-cleared ECG functionality for arrhythmia detection, alongside a major expansion into the U.S. market through e-commerce and distributor alliances.